Published in J Appl Microbiol on September 17, 2012
Inhibition of biofilm formation by T7 bacteriophages producing quorum-quenching enzymes. Appl Environ Microbiol (2014) 0.89
Bacteriophage-mediated control of a two-species biofilm formed by microorganisms causing catheter-associated urinary tract infections in an in vitro urinary catheter model. Antimicrob Agents Chemother (2014) 0.82
Ecology of Anti-Biofilm Agents II: Bacteriophage Exploitation and Biocontrol of Biofilm Bacteria. Pharmaceuticals (Basel) (2015) 0.79
Development of expanded host range phage active on biofilms of multi-drug resistant Pseudomonas aeruginosa. Bacteriophage (2016) 0.77
Biofilm models of polymicrobial infection. Future Microbiol (2015) 0.75
Phage Therapy: Future Inquiries. Postdoc J (2013) 0.75
A Review of the Recent Advances in Antimicrobial Coatings for Urinary Catheters. Acta Biomater (2016) 0.75
Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev (2002) 17.58
Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol Microbiol (1998) 17.18
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol (2008) 13.49
Bacteriophage resistance mechanisms. Nat Rev Microbiol (2010) 7.38
Engineering out the risk for infection with urinary catheters. Emerg Infect Dis (2001) 3.02
Multidrug-resistant Gram-negative infections: what are the treatment options? Drugs (2009) 2.03
Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun (1991) 1.86
Coevolution of bacteriophage PP01 and Escherichia coli O157:H7 in continuous culture. Appl Environ Microbiol (2003) 1.74
Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol (2009) 1.67
Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum. Am J Med (2006) 1.66
Bacteriophage cocktail for the prevention of biofilm formation by Pseudomonas aeruginosa on catheters in an in vitro model system. Antimicrob Agents Chemother (2009) 1.62
Escherichia coli 83972 inhibits catheter adherence by a broad spectrum of uropathogens. Urology (2003) 1.20
Pre-inoculation of urinary catheters with Escherichia coli 83972 inhibits catheter colonization by Enterococcus faecalis. J Urol (2002) 1.15
Bacteriophage therapy of Salmonella enterica: a fresh appraisal of bacteriophage therapy. J Infect Dis (2010) 1.09
Bacteriophage ecology in Escherichia coli and Pseudomonas aeruginosa mixed-biofilm communities. Appl Environ Microbiol (2010) 1.07
Coating urinary catheters with an avirulent strain of Escherichia coli as a means to establish asymptomatic colonization. Infect Control Hosp Epidemiol (2006) 1.01
Role of type 1 fimbria- and P fimbria-specific adherence in colonization of the neurogenic human bladder by Escherichia coli. Infect Immun (2002) 1.00
The adsorption of Pseudomonas aeruginosa bacteriophage phiKMV is dependent on expression regulation of type IV pili genes. FEMS Microbiol Lett (2009) 0.98
Impact of phages on two-species bacterial communities. Appl Environ Microbiol (2005) 0.94
A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization. Spinal Cord (2009) 0.92
Prevention of catheter-associated urinary tract infection. Curr Opin Infect Dis (2005) 0.90
Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis (2008) 0.89
Prevention of urinary tract infection in patients with spinal cord injury. J Spinal Cord Med (2002) 0.87
Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival. J Natl Cancer Inst (1998) 5.05
Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res (1993) 3.62
Requirement of Stat3 but not Stat1 activation for epidermal growth factor receptor- mediated cell growth In vitro. J Clin Invest (1998) 3.01
Cytokine-dependent granulocytic differentiation. Regulation of proliferative and differentiative responses in a murine progenitor cell line. J Immunol (1987) 2.54
Interleukin-6 induces prostate cancer cell growth accompanied by activation of stat3 signaling pathway . Prostate (2000) 2.03
Essential role of induced nitric oxide in the initiation of the inflammatory response after hemorrhagic shock. J Exp Med (1998) 1.96
Essential role for IL-6 in postresuscitation inflammation in hemorrhagic shock. Am J Physiol Cell Physiol (2001) 1.81
Role of biofilms in the survival of Legionella pneumophila in a model potable-water system. Microbiology (2001) 1.69
Susceptibility of penicillin-resistant pneumococci to eighteen antimicrobials: implications for treatment of meningitis. J Antimicrob Chemother (1983) 1.56
Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-tyrosine kinases. Proc Natl Acad Sci U S A (1994) 1.42
Granulocyte colony-stimulating factor activation of Stat3 alpha and Stat3 beta in immature normal and leukemic human myeloid cells. Blood (1996) 1.29
Interleukin-6 production in hemorrhagic shock is accompanied by neutrophil recruitment and lung injury. Am J Physiol (1998) 1.17
Association of altered dynamics of monocyte surface expression of human leukocyte antigen DR with immunosuppression in tuberculosis. J Infect Dis (1984) 1.16
FK 506, rapamycin, and cyclosporine: effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc (1991) 1.15
Spectrum of immunoregulatory functions and properties of human alveolar macrophages. Am Rev Respir Dis (1987) 1.13
TGF-alpha and EGFR in head and neck cancer. J Cell Biochem Suppl (1993) 1.13
Asynchronous modulation of transforming growth factor alpha and epidermal growth factor receptor protein expression in progression of premalignant lesions to head and neck squamous cell carcinoma. Clin Cancer Res (1998) 1.11
Inhibition of human squamous cell carcinoma growth in vivo by epidermal growth factor receptor antisense RNA transcribed from the U6 promoter. J Natl Cancer Inst (1998) 1.08
Inhibition of epidermal growth factor receptor gene expression and function decreases proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. Oncogene (1997) 1.07
Retinoic acid normalizes the increased gene transcription rate of TGF-alpha and EGFR in head and neck cancer cell lines. Nat Med (1996) 1.07
A dual mechanism of immunosuppression by FK-506. Differential suppression of IL-4 and IL-10 levels in T helper 2 cells. Transplantation (1993) 1.05
Molecular cloning, characterization, and tissue distribution of rat lipopolysaccharide binding protein. Evidence for extrahepatic expression. J Immunol (1994) 1.02
Lectin-induced apoptosis of tumour cells. Glycobiology (1993) 1.02
A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. Am J Physiol (1999) 1.00
Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injury. Transplantation (1999) 0.98
Biofilm formation and effect of caspofungin on biofilm structure of Candida species bloodstream isolates. Antimicrob Agents Chemother (2009) 0.97
Systemic interferon-alpha (IFN-alpha) treatment leads to Stat3 inactivation in melanoma precursor lesions. Mol Med (1999) 0.97
Induction of hepatocyte lipopolysaccharide binding protein in models of sepsis and the acute-phase response. Arch Surg (1993) 0.97
Downmodulation of TGF-alpha protein expression with antisense oligonucleotides inhibits proliferation of head and neck squamous carcinoma but not normal mucosal epithelial cells. J Cell Biochem (1998) 0.96
Cytokine induction of interferon regulatory factor-1 in hepatocytes. Surgery (1993) 0.95
G-CSF instillation into rat lungs mediates neutrophil recruitment, pulmonary edema, and hypoxia. J Leukoc Biol (1998) 0.95
Biofilm formation by gram-negative bacteria on central venous catheter connectors: effect of conditioning films in a laboratory model. J Clin Microbiol (2001) 0.95
Proteus bacteriuria is associated with significant morbidity in spinal cord injury. Spinal Cord (2006) 0.94
Establishment and characterization of an undifferentiated human T leukemia cell line which requires granulocyte-macrophage colony stimulatory factor for growth. J Immunol (1987) 0.94
Hemorrhagic shock induces G-CSF expression in bronchial epithelium. Am J Physiol (1997) 0.93
Hypoxia-inducible factor-1 activation and cyclo-oxygenase-2 induction are early reperfusion-independent inflammatory events in hemorrhagic shock. Arch Orthop Trauma Surg (2001) 0.93
Granulocyte colony-stimulating factor activates a 72-kDa isoform of STAT3 in human neutrophils. J Leukoc Biol (1998) 0.92
A bacterial interference strategy for prevention of UTI in persons practicing intermittent catheterization. Spinal Cord (2009) 0.92
Stat3 and G-CSF-induced myeloid differentiation. Leuk Lymphoma (1998) 0.91
Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium. Clin Cancer Res (1998) 0.91
Concurrent enhancement of monocyte immunoregulatory properties and effector functions by recombinant interferon-gamma. Cell Immunol (1986) 0.90
Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele. Hum Immunol (1994) 0.90
Promoters of the broad host range plasmid RK2: analysis of transcription (initiation) in five species of gram-negative bacteria. Genetics (1992) 0.89
Distinct effects of systemic infusion of G-CSF vs. IL-6 on lung and liver inflammation and injury in hemorrhagic shock. Shock (2000) 0.89
Increased expression of the differentiation-defective granulocyte colony-stimulating factor receptor mRNA isoform in acute myelogenous leukemia. Leukemia (1998) 0.89
TCR-gamma genes are rearranged but not transcribed in IL-7R alpha-deficient mice. J Immunol (1997) 0.88
IL-6 produced by Kupffer cells induces STAT protein activation in hepatocytes early during the course of systemic listerial infections. J Immunol (1998) 0.88
Impaired gut contractility following hemorrhagic shock is accompaied by IL-6 and G-CSF production and neutrophil infiltration. Dig Dis Sci (2001) 0.88
Granulocyte colony-stimulating factor (G-CSF) production in hemorrhagic shock requires both the ischemic and resuscitation phase. Arch Orthop Trauma Surg (1997) 0.87
Primary listerial infections are exacerbated in mice administered neutralizing antibody to macrophage colony-stimulating factor. J Immunol (1992) 0.87
HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies. Hum Immunol (1995) 0.86
Identification and characterization of cis elements in the STAT3 gene regulating STAT3 alpha and STAT3 beta messenger RNA splicing. Blood (2001) 0.86
Normalization of EGFR mRNA levels following restoration of wild-type p53 in a head and neck squamous cell carcinoma cell line. Int J Oncol (1998) 0.85
Feeding patterns in a small-bodied nocturnal folivore (Avahi laniger) and the influence of leaf chemistry: a preliminary study. Folia Primatol (Basel) (2006) 0.84
Rapid and simultaneous activation of Stat3 and production of interleukin 6 in resuscitated hemorrhagic shock. Arch Orthop Trauma Surg (1999) 0.84
Increased efficiency of stool culture for the detection of Salmonella and Shigella. Diagn Microbiol Infect Dis (1990) 0.83
Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression. Shock (2000) 0.83
Decreased intranuclear mobility of acute myeloid leukemia 1-containing fusion proteins is accompanied by reduced mobility and compartmentalization of core binding factor beta. Oncogene (2006) 0.83
Activation of STAT proteins in the lung of rats following resuscitation from hemorrhagic shock. Arch Orthop Trauma Surg (1998) 0.82
Interleukin-6 infusion blunts proinflammatory cytokine production without causing systematic toxicity in a swine model of uncontrolled hemorrhagic shock. J Trauma (2004) 0.82
Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. Blood (1999) 0.82
Failure of immunosuppressive mechanisms in human Schistosoma mansoni infection with hepatosplenomegaly. J Clin Microbiol (1987) 0.82
Evidence that production of interleukin 6 within the rejecting allograft coincides with cytotoxic T lymphocyte development. Transplantation (1991) 0.81
Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J Leukoc Biol (1995) 0.81
Activation of STAT proteins following ischemia reperfusion injury demonstrates a distinct IL-6 and G-CSF mediated profile. Transplant Proc (1998) 0.78
An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters. Lett Appl Microbiol (2013) 0.78
Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function. Lymphokine Cytokine Res (1993) 0.77
The role of peptide growth factors in head and neck carcinoma. Otolaryngol Clin North Am (1992) 0.77
Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence. HIV Med (2013) 0.77
Reduced hepatic transcription factor activation and expression of IL-6 and ICAM-1 after hemorrhage by NO scavenging. Arch Orthop Trauma Surg (2003) 0.77
Augmentation of TNF cytotoxicity by protein kinase C inhibitors: role of arachidonic acid and manganese superoxide dismutase. Cytokine (1995) 0.76
Making sense of the combined effect of interleukin-2 and interleukin-4 on lymphocytes using a mathematical model. Bull Math Biol (1996) 0.76
Abnormalities of immunosuppression in patients with hepatosplenic schistosomiasis mansoni. Trans Assoc Am Physicians (1983) 0.76
Granulocyte-macrophage colony-stimulating factor augmentation of T-cell receptor-dependent and T-cell receptor-independent thymocyte proliferation. Blood (1994) 0.76
Substance P receptor antagonist reverses intestinal pathophysiological alterations occurring in a novel ex-vivo model of Cryptosporidium parvum infection of intestinal tissues derived from SIV-infected macaques. J Med Primatol (2008) 0.76
A suppressor lymphokine produced by human T leukemia cell lines. Partial characterization and spectrum of activity against normal and malignant hemopoietic cells. J Exp Med (1986) 0.75
Relapsing toxic shock syndrome in the puerperium. JAMA (1985) 0.75
Proto-oncogene transcription after activation of Th-1 and Th-2 cells. Ann N Y Acad Sci (1991) 0.75
Function of hematopoietin receptor subunits in hepatic cells and fibroblasts. Ann N Y Acad Sci (1995) 0.75
Proliferation and differentiation of human myelogenous leukemia and preleukemia cells in culture: identification of stimulatory and suppressor growth factors. Haematologica (1988) 0.75
Enhancement of monocyte immunoregulatory properties and effector functions by recombinant interferon-gamma. Trans Assoc Am Physicians (1984) 0.75
Effect of granulocyte-macrophage colony-stimulating factor on lymphokine-activated killer cell induction. Blood (1993) 0.75
FK-506 inhibits proliferation and IL-4 messenger RNA production by a T-helper 2 cell line. J Surg Res (1992) 0.75
Increased blastogenic responses to worm antigen and loss of adherent suppressor cell activity after treatment for human infection with Schistosoma mansoni. J Infect Dis (1985) 0.75
Cytokine products of T-helper 2 (Th2) cells are present in rejecting sponge matrix allografts. Transplant Proc (1991) 0.75
Delineation and mapping of Stat5 isoforms activated by granulocyte colony-stimulating factor in myeloid cells. Blood Cells Mol Dis (2000) 0.75
Identification of a novel protein capable of interacting with the IL-3 receptor. J Immunol (1991) 0.75